Ellen Weisberg

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Repurposing of Kinase Inhibitors for Treatment of COVID-19”.

Repurposing of Kinase Inhibitors for Treatment of COVID-19

Pharmaceutical Research(2020)10.1007/s11095-020-02851-7

N/A

0DataRank · unranked

153 citations

Alexander Parent, Priscilla L. Yang, Martin Sattler, Qingsong Liu, Qingwang Liu +6 more

Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism

Scientific Reports(2020)10.1038/s41598-020-62076-x

N/A

0DataRank · unranked

124 citations

Xiaoxi Liu, Robert S. Magin, Laura M. Doherty, Wai Cheung Chan, Scott B. Ficarro +22 more

Inhibition of the deubiquitinase USP10 induces degradation of SYK

British Journal of Cancer(2020)10.1038/s41416-020-0731-z

N/A

0DataRank · unranked

33 citations

Chengcheng Meng, Ellen Weisberg, Abigail E. Case, Ilaria Lamberto, Robert S. Magin +9 more

Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia

Journal of Cellular and Molecular Medicine(2020)10.1111/jcmm.14927

N/A

0DataRank · unranked

28 citations

Chengcheng Meng, Abigail E. Case, Hong L. Tiv, Prafulla C. Gokhale, Sara J. Buhrlage +9 more

Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)

British Journal of Cancer(2021)10.1038/s41416-021-01441-7

N/A

0DataRank · unranked

13 citations

Abigail E. Case, Ellen Weisberg, Chengcheng Meng, Sarah R. Walker, Swati Garg +16 more

Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy

Journal of Medical Virology(2022)10.1002/jmv.28157

N/A

0DataRank · unranked

22 citations

Mikołaj Słabicki, Sita Ramaswamy, J. J. Patten, Charles Zou, Chengcheng Meng +12 more

Data from Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

(2023)10.1158/1535-7163.c.6532058.v1

N/A

0DataRank · unranked

0 citations

Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett +6 more

Data from Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

(2023)10.1158/1535-7163.c.6532058

N/A

0DataRank · unranked

0 citations

Renee D. Wright, Douglas W. McMillin, Constantine S. Mitsiades, Arghya Ray, Rosemary Barrett +6 more

Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma

Cancers(2024)10.3390/cancers16071319

N/A

0DataRank · unranked

8 citations

Swati Garg, Wei Ni, Martin Sattler, Dana Sanchez, Chengcheng Meng +8 more

Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia

Nature Reviews Clinical Oncology(2025)10.1038/s41571-025-01068-0

N/A

0DataRank · unranked

12 citations

Ellen Weisberg, Hiu Yan Lam, Donavan J. J. Tan, Andrew J. Innes, Yubin Ge +17 more

Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.118274

N/A

0DataRank · unranked

4 citations

Maurício T. Tavares, John M. Hatcher, Hyelim Kang, Tomás A. C. Kresina, Sayan Chakraborty +9 more

Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.200952

N/A

0DataRank · unranked

0 citations

Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng +13 more